Supplementary Figure Legend from Maintained Sensitivity to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer Recurring after Adjuvant Erlotinib or Gefitinib

Authors:
  • GOGeoffrey R. Oxnard
    Geoffrey R. Oxnard
  • YJYelena Y. Janjigian
    Yelena Y. Janjigian
  • MAMaria E. Arcila
    Maria E. Arcila
  • CSCamelia S. Sima
    Camelia S. Sima
  • SKSamantha L. Kass
    Samantha L. Kass
  • GRGregory J. Riely
    Gregory J. Riely
  • WPWilliam Pao
    William Pao
  • MKMark G. Kris
    Mark G. Kris
  • MLMarc Ladanyi
    Marc Ladanyi
  • CAChristopher G. Azzoli
    Christopher G. Azzoli
  • VMVincent A. Miller
    Vincent A. Miller

Abstract
No abstract available